Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

被引:111
作者
Nonkwelo, C
Skinner, J
Bell, A
Rickinson, A
Sample, J
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT VIROL & MOLEC BIOL, MEMPHIS, TN 38105 USA
[2] UNIV TENNESSEE, CTR HLTH SCI, DEPT PATHOL, MEMPHIS, TN 38163 USA
[3] UNIV BIRMINGHAM, SCH MED, DEPT CANC STUDIES, CANC RES CAMPAIGN LABS, BIRMINGHAM B15 2TJ, W MIDLANDS, ENGLAND
关键词
D O I
10.1128/JVI.70.1.623-627.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In Epstein-Barr virus (EBV)-transformed B lymphoblastoid and many Burkitt lymphoma cell lines, the EBV EBNA-1 protein is one of six viral nuclear antigens expressed from a common transcription unit under the control of one of two promoters, Wp or Cp. In contrast, EBNA-1 is the only EBV nuclear antigen expressed in Burkitt and other EBV-positive tumors. We previously identified a promoter of EBNA-1 transcription, designated Fp, in early-passage Mutu Burkitt tumor cells, and this promoter is also active in long-term Mutu and Akata Burkitt cell lines which maintain the exclusive expression of EBNA-1 characteristic of the tumor, However, transcription initiation within Fp reporter gene plasmids in EBV-negative cells occurs at positions 100 to 200 bases downstream of the Fp start site in the BamHI-Q restriction fragment. Here we demonstrate that transcription initiation within newly established Burkitt lymphoma cell lines is consistent with the transcription initiation we observed in reporter plasmids. Furthermore, previous observations of transcription from Fp to generate EBNA-1 transcripts can be attributed to lytic cycle gene expression. These data, in conjunction with our previous characterization of promoter regulatory elements, define a fourth EBNA-1 promoter, Qp, that is active in latently infected Burkitt tumor cells.
引用
收藏
页码:623 / 627
页数:5
相关论文
共 31 条
  • [1] A PROMOTER FOR THE HIGHLY SPLICED EBNA FAMILY OF RNAS OF EPSTEIN-BARR-VIRUS
    BODESCOT, M
    PERRICAUDET, M
    FARRELL, PJ
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (11) : 3424 - 3430
  • [2] EPSTEIN-BARR-VIRUS (EBV) GENE-EXPRESSION IN EBV-POSITIVE PERIPHERAL T-CELL LYMPHOMAS
    CHEN, CL
    SADLER, RH
    WALLING, DM
    SU, IJ
    HSIEH, HC
    RAABTRAUB, N
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (10) : 6303 - 6308
  • [3] A SUBPOPULATION OF NORMAL B-CELLS LATENTLY INFECTED WITH EPSTEIN-BARR-VIRUS RESEMBLES BURKITT-LYMPHOMA CELLS IN EXPRESSING EBNA-1 BUT NOT EBNA-2 OR LMP1
    CHEN, F
    ZOU, JZ
    DIRENZO, L
    WINBERG, G
    HU, LF
    KLEIN, E
    KLEIN, G
    ERNBERG, I
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3752 - 3758
  • [4] EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS
    DEACON, EM
    PALLESEN, G
    NIEDOBITEK, G
    CROCKER, J
    BROOKS, L
    RICKINSON, AB
    YOUNG, LS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 339 - 349
  • [5] EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED PROTEINS IN NASOPHARYNGEAL CARCINOMA
    FAHRAEUS, R
    FU, HL
    ERNBERG, I
    FINKE, J
    ROWE, M
    KLEIN, G
    FALK, K
    NILSSON, E
    YADAV, M
    BUSSON, P
    TURSZ, T
    KALLIN, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) : 329 - 338
  • [6] DIFFERENT EPSTEIN-BARR VIRUS-B CELL-INTERACTIONS IN PHENOTYPICALLY DISTINCT CLONES OF A BURKITTS-LYMPHOMA CELL-LINE
    GREGORY, CD
    ROWE, M
    RICKINSON, AB
    [J]. JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 1481 - 1495
  • [7] EBV GENE-EXPRESSION IN AN NPC-RELATED TUMOR
    HITT, MM
    ALLDAY, MJ
    HARA, T
    KARRAN, L
    JONES, MD
    BUSSON, P
    TURSZ, T
    ERNBERG, I
    GRIFFIN, BE
    [J]. EMBO JOURNAL, 1989, 8 (09) : 2639 - 2651
  • [8] THE EPSTEIN-BARR VIRUS (EBV) BZLF1 IMMEDIATE-EARLY GENE-PRODUCT DIFFERENTIALLY AFFECTS LATENT VERSUS PRODUCTIVE EBV PROMOTERS
    KENNEY, S
    KAMINE, J
    HOLLEYGUTHRIE, E
    LIN, JC
    MAR, EC
    PAGANO, J
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (04) : 1729 - 1736
  • [9] LOCALIZATION OF EPSTEIN-BARR-VIRUS CYTOTOXIC T-CELL EPITOPES USING RECOMBINANT VACCINIA - IMPLICATIONS FOR VACCINE DEVELOPMENT
    KHANNA, R
    BURROWS, SR
    KURILLA, MG
    JACOB, CA
    MISKO, IS
    SCULLEY, TB
    KIEFF, E
    MOSS, DJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) : 169 - 176
  • [10] KIEFF E, 1990, VIROLOGY, P1889